ECOG-ACRIN logoECOG-ACRIN logoECOG-ACRIN logoECOG-ACRIN logo
  • Home
  • Archives
  • Contact
✕
  • Filter by
  • Categories
  • Tags
  • Authors
  • Show all
  • All
  • Advocacy
  • Anal cancer
  • Artificial intelligence (AI)
  • Bladder cancer
  • Brain cancer
  • Breast cancer
  • Colorectal cancer
  • ComboMATCH
  • Esophagus cancer
  • Gallbladder cancer
  • Head and neck cancer
  • Health equity
  • Immunotherapy
  • In memory
  • Kidney cancer
  • Leukemia
  • Liver cancer
  • Lung cancer
  • Lymphoma
  • Mammography
  • Melanoma
  • Myelodysplastic syndrome
  • Myeloma
  • NCI-MATCH
  • Older adults
  • Pancreatic cancer
  • Pancreatic cysts
  • Patient education
  • Patient navigation
  • Patient-reported outcomes
  • Penis cancer
  • Personalized treatment
  • Policy
  • Precision medicine
  • Prevention
  • Prostate cancer
  • Real-world data/evidence
  • Research results
  • Sarcoma
  • Screening for cancer
  • Side effects
  • Survivorship
  • Targeted therapy
  • Upper tract urothelial cancer
  • Upper urinary tract cancer
  • Young adults
September 26, 2024
September 26, 2024
Categories
  • New Trials

Now Enrolling: The EA7222 clinical trial is testing a new treatment for patients with advanced soft tissue sarcoma

This study is for patients who have a type of soft tissue sarcoma, called undifferentiated pleomorphic sarcoma, that has spread to other areas in the body
Do you like it?
0 Read more
July 2, 2024
July 2, 2024
Categories
  • New Trials

Now Enrolling: This myeloMATCH trial is testing a new treatment for patients with acute myeloid leukemia that has a FLT3-ITD or D835 mutation

This study compares a standard initial treatment with a new approach that has the potential to put more patients into remission
Do you like it?
0 Read more
March 26, 2024
March 26, 2024
Categories
  • New Trials

Now Enrolling: ComboMATCH treatment trial E5 is testing a new option for patients with advanced solid tumors that have a KRAS G12C mutation

This study is assessing the combination of two drugs—sotorasib and panitumumab—in patients with KRAS G12C-mutated solid tumors
Do you like it?
0 Read more
January 22, 2024
January 22, 2024
Categories
  • New Trials

Now Enrolling: The EA3211 study is evaluating a new treatment strategy for certain patients with head and neck cancer

This study is for patients with head and neck squamous cell carcinoma that has spread to just a few other areas in the body
Do you like it?
0 Read more
Prev page
12345678
Next page

Office of Communications
1818 Market Street, Suite 3000
Philadelphia, PA 19103
Phone: 215.789.3631
www.ecog-acrin.org

Contact us with any questions

© 2019-2026 ECOG-ACRIN Cancer Research Group. All Rights Reserved. Designed by Create & Associates, Inc